Work

MYCgene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R

Year: 2017

Type: article

Abstract: Diffuse large B-cell lymphomas (DLBCL) are a molecularly and clinically heterogeneous group of diseases. Specific molecular events such as MYC rearrangement (MYC-R), which occurs in a number of B-c...

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2017.1339882

Authors: Catherine Lai, Mark Roschewski, Christopher Melani, Stefania Pittaluga, Margaret Shovlin, Seth M. Steinberg, Kieron Dunleavy, Svetlana Pack, Elaine S. Jaffe, Wyndham H. Wilson

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institutes of Health

Award: G9000172378

OpenAlex ID: W2643208366

FWCI: 1.864

Cites: 20

Cited by: 14

Related to: 10